Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 89.83
+5.61 (6.66%)
At close: Aug 17, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 46.15 billion as of August 17, 2026. Its market cap has increased by 81.47% in one year.
Market Cap
46.15B
Enterprise Value
47.32B
Revenue
19.51B
Ranking
n/a
PE Ratio
33.02
Stock Price
89.83
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 46.15B, an increase of 433.02%. That is a compound annual growth rate of 6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 49.22B | 118.72% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 98.50B |
| Sanofi India | 74.77B |
| FDC Limited | 57.68B |
| Bliss GVS Pharma | 55.68B |
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |
| Kwality Pharmaceuticals | 35.74B |